183
Views
3
CrossRef citations to date
0
Altmetric
Review

Anti-trypanosomatid structure-based drug design – lessons learned from targeting the folate pathway

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1029-1045 | Received 29 Apr 2022, Accepted 12 Aug 2022, Published online: 07 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Juan Carlos Gabaldón-Figueira, Nieves Martinez-Peinado, Elisa Escabia, Albert Ros-Lucas, Eric Chatelain, Ivan Scandale, Joaquim Gascon, María-Jesús Pinazo & Julio Alonso-Padilla. (2023) State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation. Research and Reports in Tropical Medicine 14, pages 1-19.
Read now
Francesco Melfi, Simone Carradori, Cristina Campestre, Entela Haloci, Alessandra Ammazzalorso, Rossella Grande & Ilaria D’Agostino. (2023) Emerging compounds and therapeutic strategies to treat infections from Trypanosoma brucei: an overhaul of the last 5-years patents. Expert Opinion on Therapeutic Patents 33:3, pages 247-263.
Read now

Articles from other publishers (1)

Chonny Herrera-Acevedo, Renata Priscila Barros de Menezes, Natália Ferreira de Sousa, Luciana Scotti, Marcus Tullius Scotti & Ericsson Coy-Barrera. (2023) Kaurane-Type Diterpenoids as Potential Inhibitors of Dihydrofolate Reductase-Thymidylate Synthase in New World Leishmania Species. Antibiotics 12:4, pages 663.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.